Latest nausea Stories
- Fewer patients on Tasigna vs. Gleevec had their leukemia progress to advanced stage, a key goal of treatment in CML and important clinical benefit (1) EAST HANOVER, N.J., Dec.
78 Percent of Patients Treated With BLINCYTO Experienced a Complete Minimal Residual Disease (MRD) Response After One Treatment Cycle THOUSAND OAKS, Calif., Dec.
- 24 UCB-sponsored presentations including new data on VIMPAT® (lacosamide) BRUSSELS, Dec.
Only FDA-approved and only Pregnancy Category A prescription treatment for Nausea and Vomiting of Pregnancy is now available in Tennessee through the state-administered Medicaid Drug Rebate Program
-- Trial Met Primary Efficacy Endpoint with Statistical Significance After 12 Weeks of Treatment -- WOODCLIFF LAKE, N.J. and SAN DIEGO, Nov. 3, 2014 /PRNewswire/ -- Eisai Inc.
-- Trial Met Primary Safety Objective After 12 Weeks of Treatment -- WOODCLIFF LAKE, N.J. and SAN DIEGO, Oct. 28, 2014 /PRNewswire/ -- Eisai Inc. and Arena Pharmaceuticals, Inc.
Only FDA-approved and only Pregnancy Category A prescription treatment for Nausea and Vomiting of Pregnancy is now available in California and Nebraska through state-administered Medicaid Drug Rebate
Duchesnay USA encourages pregnant women suffering from nausea and vomiting of pregnancy to speak with their healthcare professional about the only FDA-approved and only Pregnancy Category A prescription
- VIMPAT® (lacosamide) C-V approved in the U.S. as monotherapy in the treatment of partial-onset seizures in adults with epilepsy(1) BRUSSELS, Sept.
ROSEMONT, Pa., March 27, 2014 /PRNewswire/ -- Duchesnay USA is pleased to announce Kosher and Halal certifications for Diclegis(®) (doxylamine succinate 10mg and pyridoxine hydrochloride -vitamin
- a meat pie that is usually eaten at Christmas in Quebec